1. Home
  2. ENVA vs NUVB Comparison

ENVA vs NUVB Comparison

Compare ENVA & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$137.66

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.66

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
NUVB
Founded
2011
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
2.9B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
ENVA
NUVB
Price
$137.66
$4.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$173.00
$11.22
AVG Volume (30 Days)
258.5K
4.8M
Earning Date
04-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
55.05
N/A
EPS
11.52
N/A
Revenue
$3,151,653,000.00
N/A
Revenue This Year
$149.91
$182.76
Revenue Next Year
$15.38
$91.83
P/E Ratio
$12.35
N/A
Revenue Growth
18.58
N/A
52 Week Low
$79.41
$1.57
52 Week High
$176.68
$9.75

Technical Indicators

Market Signals
Indicator
ENVA
NUVB
Relative Strength Index (RSI) 38.88 33.85
Support Level $135.44 $3.92
Resistance Level $149.49 $5.73
Average True Range (ATR) 5.98 0.35
MACD -0.36 -0.07
Stochastic Oscillator 17.98 25.27

Price Performance

Historical Comparison
ENVA
NUVB

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: